Anacor Pharmaceuticals Inc $24.81

down 0.00


19/9/2014 04:00 PM  |  NASDAQ : ANAC  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ANAC Trend Analysis - it has outperformed the S&P 500 by 125%

Partner Headlines

  1. Paulson Bets Again On Mallinckrodt

    GuruFocus
  2. Benzinga's Volume Movers

    Benzinga
  3. Anacor Pharmaceuticals And Sandoz Enter Into An Agreement For The Commercialization ...

    Benzinga
  4. 5-Star Biotech Stock Watch: Anacor Pharmaceuticals

    Benzinga
  5. Mid-Afternoon Market Update: Markets Go Red as Anadarko Rallies on Settlement ...

    Benzinga
  6. Mid-Day Market Update: US Stocks Fall; Google Shares Rise After Stock Split

    Benzinga
  7. US Stock Futures Up Ahead Of Chicago PMI

    Benzinga
  8. Earnings Scheduled For March 13, 2014

    Benzinga
  9. Anacor Pharmaceuticals Announces Successful Completion of End-of-Phase ...

    Benzinga
  10. Valeant Pharmaceuticals

    IBD
  11. Anacor Pharmaceuticals Awarded $13.5M in Research Agreement with Defense ...

    Benzinga
  12. Benzinga's Top Pre-Market Gainers

    Benzinga
  13. Anacor Pharmaceuticals Announces Award of $100M in Arbitration with Valeant ...

    Benzinga
  14. These Three Speculative Companies Are Loved By Insiders and Institutions

    Benzinga
  15. Weekly CFO Buys Highlight

    GuruFocus
  16. 3 Great Dividend Stocks at All-Time Highs

    GuruFocus
  17. Stocks Hitting 52-Week Highs

    Benzinga
  18. Stocks Hitting 52-Week Lows

    Benzinga
  19. Stocks Hitting 52-Week Lows

    Benzinga
  20. A Peek Into The Market Before The Trading Starts

    Benzinga
  21. Anacor Pharmaceuticals Announces Positive Phase 3 Trial Results for Tavaborole ...

    Benzinga
  22. Anacor Pharmaceuticals Announces Positive Results From Phase 2 Trial of ...

    Benzinga
  23. Anacor Pharmaceuticals Inc Reports Operating Results (10-Q)

    GuruFocus
  24. Anacor Pharmaceuticals Prices $24 Million Public Offering of Common Stock

    Benzinga
  25. Anacor Pharmaceuticals Announces That GSK Has Discontinued Clinical Development ...

    Benzinga
  26. (ANAC) CFO Geoffrey M. Parker buys 5,000 Shares

    GuruFocus
  27. Health Care Sector Wrap

    FoxBusiness
  28. (ANAC) CFO Geoffrey M. Parker buys 7,954 Shares

    GuruFocus
  29. Anacor Pharmaceuticals Appoints Paul L. Berns to Its Board of Directors

    Benzinga
  30. Earnings Scheduled For March 5

    Benzinga
  31. Anacor Pharmaceuticals Announces the Sale of 3.25 Million Shares of Common ...

    Benzinga
  32. Anacor Pharmaceuticals Announces Positive Preliminary Results from Two ...

    Benzinga
  33. Anacor Pharmaceuticals Down 14.4% After GlaxoSmithKline Pauses Ongoing ...

    Benzinga
  34. Stocks To Watch For December 28

    Benzinga
  35. Anacor Pharma Registers To Offer Up To $50M In Mixed Securities

    Benzinga
  36. Wedbush Maintains Outperform, $13 Target on Anacor

    Benzinga
Trading Center